Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and De-listing, vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017, 20190207-23 dated 07 Feb 2019, 20200528-32 dated 28 May 2020 and 20201102-43 dated 02 Nov 2020 has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.
All Market Participants are hereby informed that an offer for delisting of equity shares is made by Veego Pharma LLC (“Acquirer” / “Promoter” / “Veego”) to the public shareholders of Wintac Limited (“Company”) to acquire up to 45,12,144 (forty five lakh twelve thousand one hundred forty four) Equity Shares of the Company representing 45.01% (forty five point zero one percent) of the Share Capital, held by the Public Shareholders, at the floor price of Rs. 220/- (Rupees Two Hundred Twenty only) per Offer Share of face value of Rs. 10/- each of the Company (“Equity Shares”) in accordance with the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, as amended (“Delisting Regulations”), as amended from time to time, from November 11, 2020 to November 18, 2020.
Market participants are further requested to note that the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.
Atul Dhotre
Senior Manager
Listing Sales & Ops
November 05,2020
|